Study of Libifem® for fertility in women with low egg reserve
Part of Women’s health & pregnancy clinical trials.
This trial tests a supplement called Libifem® (VL-GF-01) to see if it can improve fertility in women with low egg reserve (diminished ovarian reserve). The study looks for women who want to conceive naturally and meet specific medical criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 35 years old and wish to become pregnant.
- You have been trying to conceive for at least one year without protection and have regular sex (at least twice a week).
- Your AMH (a measure of egg supply) is less than 1.5 but more than 0 ng/ml.
- You have never had IVF treatment.
- You do not have PCOS, Stage 3 or 4 endometriosis, or certain other health issues listed in the trial rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to help eggs mature outside the body during IVF. It is for women who need IVF and have good egg reserves, to see if it can improve their chances of a healthy pregnancy.
This study tests a different type of fertility medication to help women who had fewer than 9 eggs retrieved in a previous IVF cycle. It's designed for women between 18 and 40 with a specific hormone profile, and aims to improve egg collection results.
This trial tests whether giving extra LH hormone during an IVF cycle can improve outcomes for women who naturally have low LH levels. It may help your eggs develop better.
This trial tests whether a special herbal formula, given before an IVF cycle, can improve pregnancy success in women with diminished ovarian reserve. It is for women who are aged 22 to 39, have low egg supply, and have a Traditional Chinese Medicine diagnosis of Kidney Deficiency.
This trial tests whether a traditional Chinese herbal medicine called Yulinzhu can help women with diminished ovarian reserve (low egg count or quality) improve their chances of pregnancy. The study includes 12 weeks of treatment followed by IVF if you don't conceive naturally.
This study tests whether giving testosterone to women with low ovarian reserve and a specific genetic variation in their androgen receptor can improve IVF outcomes. It may help women who have not responded well to previous fertility treatments.
Hear when a new Female Fertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.